Rollie Carlson, Ph.D., is the CEO at Immunexpress Inc., bringing extensive commercial and operational expertise from the life sciences, molecular diagnostics, and pharmaceuticals industries. Previously, Rollie held various leadership roles at Abbott Laboratories from 1986 to 2006, including Executive, Global Director of Sales & Marketing, and Vice President in Business Development and Strategic Planning. They served as President & CEO of Asuragen from 2006 to 2014, establishing company operations and developing multiple clinical products while raising significant funding. Rollie was also a founder of Mirna Therapeutics, where they led early-stage research and intellectual property strategies. Prior to their current position, Rollie was the President & CEO of WaferGen Biosystems from 2015 to 2017.
This person is not in the org chart
This person is not in any teams
This person is not in any offices